55 results
8-K
EX-99.1
ANAB
AnaptysBio Inc
27 Nov 23
Entry into a Material Definitive Agreement
4:17pm
successfully completed IND-enabling studies and manufacturing scale-up. Anaptys will assume responsibility for all future clinical development.
In exchange
424B5
qedjoob tb1x
8 Nov 22
Prospectus supplement for primary offering
4:34pm
8-K
EX-10.2
add87sw8t cr
29 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.1
ml7o2cy14d08
29 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.3
8txzy5oyd tyv2nae04r
29 Apr 22
Departure of Directors or Certain Officers
4:06pm